scholarly journals Conservative treatment of idiopathic facial palsy. Effects of the administration of high-dose steroids in Bell's palsy.

1992 ◽  
Vol 95 (2) ◽  
pp. 172-177 ◽  
Author(s):  
HIROO INAMURA ◽  
HITOSHI TOJIMA ◽  
OSAMU SAITO ◽  
HIROYUKI MAEYAMA ◽  
KAZUHIKO TAKEDA ◽  
...  
2021 ◽  
Vol 17 (1) ◽  
Author(s):  
Yared Zenebe Zewde

Abstract Background Melkersson–Rosenthal syndrome (MRS) is a rare neuro-mucocutaneous disorder of unknown cause, clinically characterized by a triad of recurrent facial palsy, orofacial swelling, and fissured tongue. It is frequently seen in females in their second and third decades of life. MRS is diagnosed based on clinical features and it is rarely possible to observe all the classical triad symptoms at the same time. The disorder may cause recurring peripheral facial palsy that is wrongly diagnosed as recurrent Bell’s palsy Case presentation A 25-year-old female patient was presented to the neurology clinic of Tikur Anbessa Specialized Hospital in Addis Ababa complaining of recurrent left-side peripheral facial weakness, facial swelling and fissured tongue of 5 days duration. Her past medical history was positive for similar symptoms, for which she was diagnosed with Bell’s palsy and received oral corticosteroid treatment. On examination left side lower facial swelling with flat naso-labial fold and fissured tongue were identified. After excluding other mimickers, she was diagnosed with Melkersson–Rosenthal syndrome and completely recovered with high dose of corticosteroid treatment. Conclusion Melkersson–Rosenthal syndrome may present with the classic triads of symptoms, but mostly it shows an incomplete clinical pattern. Therefore, when clinicians including allergists encountered patients with facial swelling and facial palsy, they should have to consider MRS in their differential diagnosis and specifically assess for recurrent facial palsy and fissured tongue. Unlike true angioedema, the facial swelling in MRS often develops gradually and it might cause permanent swelling with cosmetic disfigurement from multiple relapses, which can be prevented by early detection and timely initiation of treatment.


2014 ◽  
Vol 124 (2) ◽  
pp. 107-109 ◽  
Author(s):  
Baochun Sun ◽  
Chengyong Zhou ◽  
Zeli Han

2020 ◽  
Vol 2020 ◽  
pp. 1-7
Author(s):  
Weizheng Zhong ◽  
Haibo Yu ◽  
Xiaodan Rao ◽  
Jianhuang Wu ◽  
Yanhua Gou ◽  
...  

To determine if the effect of manipulative acupuncture monitored by laser speckle contrast imaging (LSCI) can improve facial blood perfusion in patients with severe Bell’s palsy. This randomized, single-blind, controlled trial included 120 newly diagnosed patients (within 14 days) with severe Bell’s palsy (House–Brackmann grading system (HBGS) ≥ grade IV). The patients were randomized (1 : 1) to receive either acupoints acupuncture combined with manipulations of twirling, lifting, and thrusting treatments (manipulative acupuncture) or acupoints acupuncture therapy alone (simple acupuncture). These treatments consisted of a total of 24 sessions, three times per week, and each treatment lasted for 30 min. Following 8 weeks of treatment and 6 months after the initial onset of facial palsy, facial nerve functioning was scored (HBGS) and clinical efficacy was measured. The patients’ facial blood perfusion significantly improved following manipulative acupuncture assisted by LSCI compared with that at baseline ( P < 0.01 ). At the conclusion of the 8-week treatment, both groups showed improvement; however, the recovery rate was significantly different (manipulative acupuncture 53.3% vs. simple acupuncture 33.9%, P < 0.05 ). Follow-up analysis at 6 months after the onset of facial palsy revealed a significantly higher recovery rate (91.7% vs. 78.0%; P < 0.05 ). In addition, the number of treatments in the observation group was less than that in the simple acupuncture therapy group ( P < 0.05 ). Compared with simple acupuncture therapy, manipulative acupuncture therapy led to a more significant recovery rate in the treatment of severe Bell’s palsy and required a shorter course of treatment. This trial was registered with ChiCTR1800019463.


2019 ◽  
Vol 122 (3) ◽  
pp. 258-259
Author(s):  
Takashi Fujiwara ◽  
Yasuharu Haku ◽  
Takuya Miyazaki ◽  
Atsuhiro Yoshida ◽  
Shin-ich Sato ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document